Keywords
How to Cite
Abstract
In this work the effect of RHAMM (receptor hyaluronan-mediated motility)-target peptides was investigated on the viability, apoptosis and necrosis of prostate cancer cells (PC3m-LN4). It has been established that RHAMM-target peptides inhibited on 90 % cell viability of PC3m-LN4 cells at a concentration of 10 ug / ml (2х10-7 M) for 48 h. It has shown that RHAMM-target peptides induced apoptosis and inhibited necrosis of tumor cells. RHAMM-target peptide had no effect on fibroblasts (non-tumor cells) and fibroblasts (RHAMM-/-). The studies also revealed that RHAMM-target peptides enhanced activity of caspase-3/7 in cancer cells.References
Becker-Weimann S., Xiong G., Furuta S. et al. NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals // Oncotarget. - 2013. - Vol. 4. - No. 11. - P. 2010-2020.
Bhat R, Bissell MJ. Of plasticity and specificity: dialectics of the micro- and macro-environment and the organ phenotype // Wiley Interdiscip Rev Membr Transp Signal. - 2014. - Vol. 3. - No. 2. - P. 147-163.
Brownfield D.G., Venugopalan G., Lo A. et al. Patterned collagen fibers orient branching mammary epithelium through distinct signaling modules // Curr Biol. - 2013. - Vol. 23. - No. 8. - P. 703-709.
Dicker K.T., Gurski L.A., Pradhan-Bhatt S. et al. Hyaluronan: a simple polysaccharide with diverse biological functions // Acta Biomater. - 2014. - Vol. 10. - No. 4. - P. 1558-1570.
Lin S.L., Chang D., Chiang A., and Ying S. Androgen receptor regulates CD168 expression and signaling in prostate cancer // Carcinogenesis. - 2008. - Vol. 29. - P. 282-290.
Lokeshwar V.B., Lopez L.E. et al. Antitumor activity of hyaluronic acid synthesis inhibitor 4-Methylumbelliferone in prostate cancer cells // Cancer Res. - 2010. - Vol. 70. - P. 2613-2623.
Luyt L.G., Turley E.A., Esguerra K.V. Rhamm binding peptides // International Patent WO2011/150495. - London Health Sciences Centre Research Inc. - 2011.
M de V., Els-Heindl S., Beck-Sickinger A.G. Automated solid-phase peptide synthesis to obtain therapeutic peptides // Beilstein J. Org. Chem. - 2014. - Vol. 10. - P. 1197-1212.
Misra S, Hascall VC, Markwald RR, Ghatak S. Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer // Front Immunol. - 2015. - Vol. 6. - P. 201-210.
Nagy N., Kuipers H.F., Frymoyer A.R. et al. 4-methylum-belliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer // Front Immunol. - 2015. - Vol. 6. - P. 123-133.
Nikitovic D., Tzardi M., Berdiaki A. et al. Cancer microenvironment and inflammation: role of hyaluronan. // Front Immunol. - 2015. - Vol. 6. - P. 169-179.
Panda P.K., Mukhopadhyay S., Das D.N. Mechanism of autophagic regulation in carcinogenesis and cancer therapeutics // Semin. Cell Dev. Biol. - 2015. - Vol. 39. - P. 43-55.
Rizzardi A.E., Vogel R.I., Koopmeiners J.S. et al. Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors // Cancer. - 2014. - Vol. 120. - No.12. - P. 1800-1809.
Stivarou T., Patsavoudi E. Extracellular molecules involved in cancer cell invasion // Cancers (Basel). - 2015. - Vol. 7. - No. 1. - P. 238-265.
Tabarkiewicz J, Giannopoulos K. Definition of a target for immunotherapy and results of the first Peptide vaccination study in chronic lymphocytic leukemia // Transplant Proc. - 2010. - Vol. 42. - No. 8. - P. 3293-3296.
Tammi R.H., Kultti A., Kosma V.M. et al. Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan // Semin. Cancer. Biol. - 2008. - Vol. 18. - P. 288-295.
Tangutoori S., Baldwin P., Sridhar S. PARP inhibitors: A new era of targeted therapy // Maturitas. - 2015. - Vol. 81. - No.1. - P. 5-9.
Tolg C., Hamilton S. J., Morningstar L. et al. RHAMM promotes interphase microtubule instability and mitotic spindle integrity trough MEK1/ERK1, 2 activity // J. Biol. Chem. - 2010. - Vol. 285. - P. 26461-26474.
Tolg C., Hamilton S.R., Nakrieko K.A. et al. Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 moto-genic signaling, leading to defective skin wound repair // J. Cell Biol. - 2006. - Vol. 175. - P. 1017-1028.
Zhang P., Lo A., Huang Y. et al. Identification of genetic loci that control mammary tumor susceptibility through the host microenvironment // Sci. Rep. - 2015. - Vol. 5. - P. 8919.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...